Citations (115)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Mengnan Zhao, Na Li & Hong Zhou. (2023) SGLT1: A Potential Drug Target for Cardiovascular Disease. Drug Design, Development and Therapy 17, pages 2011-2023.
Read now
Read now
Emily Brown, John P. H. Wilding, Uazman Alam, Thomas M. Barber, Janaka Karalliedde & Daniel J. Cuthbertson. (2021) The expanding role of SGLT2 inhibitors beyond glucose-lowering to cardiorenal protection. Annals of Medicine 53:1, pages 2072-2089.
Read now
Read now
Marc S Rendell. (2019) The journey from gene knockout to clinical medicine: telotristat and sotagliflozin. Drug Design, Development and Therapy 13, pages 817-824.
Read now
Read now
Marc S. Rendell. (2018) Sotagliflozin: a combined SGLT1/SGLT2 inhibitor to treat diabetes. Expert Review of Endocrinology & Metabolism 13:6, pages 333-339.
Read now
Read now
Marc S. Rendell. (2018) Efficacy and safety of sotagliflozin in treating diabetes type 1. Expert Opinion on Pharmacotherapy 19:3, pages 307-315.
Read now
Read now
Articles from other publishers (110)
Hsiao-Huai Kuo, Yau-Huei Lai, Po-Lin Lin, Hsin-Hao Chen, Chung-Lieh Hung, Lawrence Yu-Min Liu & Chih-Kuang Yeh. (2023) Effects of canagliflozin on cardiac remodeling and hemodynamic parameters in patients with type 2 diabetes mellitus. Scientific Reports 13:1.
Crossref
Crossref
Kuo Chen, Hua Zhang, Bo Jiang, Jingjing Chen & Tao Zhang. (2023) d-allulose reduces postprandial glucose absorption in small intestine by competitive binding to glucose transport sites. Food Bioscience 56, pages 103305.
Crossref
Crossref
Jiyifan Li, Chenyang Zhu, Jingru Liang, Jiarong Hu, Haiyang Liu, Zihan Wang, Ruifang Guan, Junwei Chow, Shiwei Yan, Longzhou Li, Fuyan Ma & Guo Ma. (2023) Cardiovascular benefits and safety of sotagliflozin in type 2 diabetes mellitus patients with heart failure or cardiovascular risk factors: a bayesian network meta-analysis. Frontiers in Pharmacology 14.
Crossref
Crossref
Satoko Tsunokake, Erina Iwabuchi, Yasuhiro Miki, Ayako Kanai, Yoshiaki Onodera, Hironobu Sasano, Takanori Ishida & Takashi Suzuki. (2023) SGLT1 as an adverse prognostic factor in invasive ductal carcinoma of the breast. Breast Cancer Research and Treatment 201:3, pages 499-513.
Crossref
Crossref
Tifany Chu, Pattareeya Yottasan, Livia de Souza Goncalves, Apurva A. Oak, Ruxian Lin, Ming Tse, Mark Donowitz & Onur Cil. (2023) Calcium-sensing receptor activator cinacalcet for treatment of cyclic nucleotide-mediated secretory diarrheas. Translational Research.
Crossref
Crossref
Yu Zhang, Panpan Xie, Yamei Li, Zhixing Chen & Aixin Shi. (2023) Mechanistic evaluation of the inhibitory effect of four SGLT-2 inhibitors on SGLT 1 and SGLT 2 using physiologically based pharmacokinetic (PBPK) modeling approaches. Frontiers in Pharmacology 14.
Crossref
Crossref
Nesreen M.I.M. Elkomy, Amina El-Shaibany, Gehad M. Elnagar, Ahmed S. Abdelkhalek, Hassan Al-Mahbashi, Mahmoud M. Elaasser, Salwa M. Raweh, Maha A. Aldiyarbi & Ali E. Raslan. (2023) Evaluation of acute oral toxicity, anti-diabetic and antioxidant effects of Aloe vera flowers extract. Journal of Ethnopharmacology 309, pages 116310.
Crossref
Crossref
Yu-Chan Chang, Ming-Hsien Chan, Yi-Fang Yang, Chien-Hsiu Li & Michael Hsiao. (2023) Glucose transporter 4: Insulin response mastermind, glycolysis catalyst and treatment direction for cancer progression. Cancer Letters 563, pages 216179.
Crossref
Crossref
Tatsuya Sato, Hidemichi Kouzu, Toshiyuki Yano, Ichiro Sakuma, Masato Furuhashi & Noritsugu Tohse. (2023) Potential favorable action of sodium-glucose cotransporter-2 inhibitors on sudden cardiac death: a brief overview. Frontiers in Cardiovascular Medicine 10.
Crossref
Crossref
Mitsunori Fujino, Naoki Morito, Takuto Hayashi, Masami Ojima, Shun Ishibashi, Akihiro Kuno, Seizo Koshiba, Kunihiro Yamagata & Satoru Takahashi. (2023) Transcription factor c-Maf deletion improves streptozotocin-induced diabetic nephropathy by directly regulating Sglt2 and Glut2. JCI Insight 8:6.
Crossref
Crossref
Jennifer Matthews, Moira Hibbs, Lakshini Herat, Markus Schlaich & Vance Matthews. (2023) The Sympathetic Nervous System Regulates Sodium Glucose Co-Transporter 1 Expression in the Kidney. Biomedicines 11:3, pages 819.
Crossref
Crossref
Joshua Solomon, Maria Carolina Festa, Yiannis S. Chatzizisis, Ratna Samanta, Rita S. Suri & Thomas A. Mavrakanas. (2023) Sodium-glucose co-transporter 2 inhibitors in patients with chronic kidney disease. Pharmacology & Therapeutics 242, pages 108330.
Crossref
Crossref
Hang Chee Erin Shum, Ke Wu, Jaydutt Vadgama & Yong Wu. (2023) Potential Therapies Targeting the Metabolic Reprogramming of Diabetes-Associated Breast Cancer. Journal of Personalized Medicine 13:1, pages 157.
Crossref
Crossref
Molykutty J. Aryankalayil, Michelle A. Bylicky, Shannon Martello, Sunita Chopra, Mary Sproull, Jared M. May, Aman Shankardass, Laurel MacMillan, Claire Vanpouille-Box, Juan Dalo, Kevin M. K. Scott & C. Norman Coleman. (2023) Microarray analysis identifies coding and non-coding RNA markers of liver injury in whole body irradiated mice. Scientific Reports 13:1.
Crossref
Crossref
Jothydev Kesavadev, Fatema Jawad, Asma Deeb, Ankia Coetzee, M. A. Jalil Ansari, Dina Shrestha, Noel Somasundaram & Sanjay Kalra. 2023. The Diabetes Textbook. The Diabetes Textbook
127
142
.
Jonali Ramani, Harshil Shah, Vivek K. Vyas & Manmohan Sharma. (2022) A review on the medicinal chemistry of sodium glucose co-transporter 2 inhibitors (SGLT2-I): Update from 2010 to present. European Journal of Medicinal Chemistry Reports 6, pages 100074.
Crossref
Crossref
Siti Hajar Adam, Noor Mohd Nasri, Mohd Izhar Ariff Mohd Kashim, Erny Haslina Abd Latib, Muhammad Amirul Aiman Ahmad Juhari & Mohd Helmy Mokhtar. (2022) Potential health benefits of Nigella sativa on diabetes mellitus and its complications: A review from laboratory studies to clinical trials. Frontiers in Nutrition 9.
Crossref
Crossref
Alef Aragão Carneiro dos Santos, Luiz Eduardo Rodrigues, Amanda Lins Alecrim-Zeza, Liliane de Araújo Ferreira, Caio dos Santos Trettel, Gabriela Mandú Gimenes, Adelson Fernandes da Silva, Celso Pereira Batista Sousa-Filho, Tamires Duarte Afonso Serdan, Adriana Cristina Levada-Pires, Elaine Hatanaka, Fernanda Teixeira Borges, Marcelo Paes de Barros, Maria Fernanda Cury-Boaventura, Gisele Lopes Bertolini, Priscila Cassolla, Gabriel Nasri Marzuca-Nassr, Kaio Fernando Vitzel, Tania Cristina Pithon-Curi, Laureane Nunes Masi, Rui Curi, Renata Gorjao & Sandro Massao Hirabara. (2022) Molecular and cellular mechanisms involved in tissue-specific metabolic modulation by SARS-CoV-2. Frontiers in Microbiology 13.
Crossref
Crossref
Aleix Navarro Garrido, Young Chul Kim, Yuji Oe, Haiyan Zhang, Maria Crespo-Masip, Helen A. Goodluck, Sadhana Kanoo, Paul W. Sanders, Stefan Bröer & Volker Vallon. (2022)
Aristolochic acid-induced nephropathy is attenuated in mice lacking the neutral amino acid transporter B
0
AT1 (
Slc6a19
)
. American Journal of Physiology-Renal Physiology 323:4, pages F455-F467.
Crossref
Crossref
Jun Gi Hwang, SeungHwan Lee, Wan Huh, Jumi Han, Jaeseong Oh, In‐Jin Jang & Kyung‐Sang Yu. (2022) Dose‐dependent glucosuria of DWP16001, a novel selective sodium–glucose cotransporter‐2 inhibitor, in healthy subjects. British Journal of Clinical Pharmacology 88:9, pages 4100-4110.
Crossref
Crossref
Dominik Kurczyński, Bartosz Hudzik, Marta Jagosz, Jan Zabierowski, Jolanta Nowak, Andrzej Tomasik, Arkadiusz Badziński, Piotr Rozentryt & Mariusz Gąsior. (2022) Sodium-Glucose Cotransporter-2 Inhibitors-from the Treatment of Diabetes to Therapy of Chronic Heart Failure. Journal of Cardiovascular Development and Disease 9:7, pages 225.
Crossref
Crossref
Alok Sharma, Rakesh Chawla, Jasleen Kaur & Reecha Madaan. (2022) An Overview of Phytotherapy Used in the Management of Type II Diabetes. Current Diabetes Reviews 18:6.
Crossref
Crossref
Felicitas Piossek, Sascha Beneke, Nadja Schlichenmaier, Goran Mucic, Sabine Drewitz & Daniel R. Dietrich. (2022) Physiological oxygen and co-culture with human fibroblasts facilitate in vivo-like properties in human renal proximal tubular epithelial cells. Chemico-Biological Interactions 361, pages 109959.
Crossref
Crossref
Yuji Oe & Volker Vallon. (2022) The Pathophysiological Basis of Diabetic Kidney Protection by Inhibition of SGLT2 and SGLT1. Kidney and Dialysis 2:2, pages 349-368.
Crossref
Crossref
Yao Pan, Hongyan Li, Fereidoon Shahidi, Ting Luo & Zeyuan Deng. (2022) Interactions among dietary phytochemicals and nutrients: Role of cell membranes. Trends in Food Science & Technology 124, pages 38-50.
Crossref
Crossref
Sanaa Sharari, Mustapha Aouida, Idris Mohammed, Basma Haris, Ajaz Ahmad Bhat, Iman Hawari, Sabah Nisar, Igor Pavlovski, Kabir H. Biswas, Najeeb Syed, Selma Maacha, Jean-Charles Grivel, Maryam Saifaldeen, Johan Ericsson & Khalid Hussain. (2022) Understanding the Mechanism of Dysglycemia in a Fanconi-Bickel Syndrome Patient. Frontiers in Endocrinology 13.
Crossref
Crossref
Angeliki M Angelidi, Matthew J Belanger, Alexander Kokkinos, Chrysi C Koliaki & Christos S Mantzoros. (2022) Novel Noninvasive Approaches to the Treatment of Obesity: From Pharmacotherapy to Gene Therapy. Endocrine Reviews 43:3, pages 507-557.
Crossref
Crossref
Alyssa M. Weinrauch, Alexander M. Clifford, Erik J. Folkerts, Christina M. Schaefer, Marina Giacomin & Greg G. Goss. (2022)
Molecular identification and postprandial regulation of glucose carrier proteins in the hindgut of Pacific hagfish,
Eptatretus stoutii
. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 322:4, pages R336-R345.
Crossref
Crossref
Ying Zhang, Yanna Pan, Jiaqi Li, Zeng Zhang, Yanming He, Hongjie Yang & Ping Zhou. (2022) Inhibition on α-Glucosidase Activity and Non-Enzymatic Glycation by an Anti-Oxidative Proteoglycan from Ganoderma lucidum. Molecules 27:5, pages 1457.
Crossref
Crossref
Kwame Anokye Amoabeng, Sanna Laurila, Luis Eduardo Juárez-Orozco, Anne Beate Langeland Marthinsen, Dariusz Moczulski, Eleni Rebelos & Prince Dadson. (2021) The utilization of positron emission tomography in the evaluation of renal health and disease. Clinical and Translational Imaging 10:1, pages 59-69.
Crossref
Crossref
Amar van Laar, Charlotte Grootaert, Filip Van Nieuwerburgh, Dieter Deforce, Tom Desmet, Koen Beerens & John Van Camp. (2022) Metabolism and Health Effects of Rare Sugars in a CACO-2/HepG2 Coculture Model. Nutrients 14:3, pages 611.
Crossref
Crossref
Takayuki Ota, Takeshi Ishikawa, Tomoki Sakakida, Yuki Endo, Shinya Matsumura, Juichirou Yoshida, Yasuko Hirai, Katsura Mizushima, Kaname Oka, Toshifumi Doi, Tetsuya Okayama, Ken Inoue, Kazuhiro Kamada, Kazuhiko Uchiyama, Tomohisa Takagi, Hideyuki Konishi, Yuji Naito & Yoshito Itoh. (2022) Treatment with broad-spectrum antibiotics upregulates Sglt1 and induces small intestinal villous hyperplasia in mice. Journal of Clinical Biochemistry and Nutrition 70:1, pages 21-27.
Crossref
Crossref
Masaki Ryuzaki, Kazutoshi Miyashita, Masaaki Sato, Hiroyuki Inoue, Kentaro Fujii, Aika Hagiwara, Asuka Uto, Sho Endo, Takuma Oshida, Kenichiro Kinouchi & Hiroshi Itoh. (2022) Activation of the intestinal tissue renin-angiotensin system by transient sodium loading in salt-sensitive rats. Journal of Hypertension 40:1, pages 33-45.
Crossref
Crossref
Worood Sirhan & Ron Piran. 2022. Peptide and Peptidomimetic Therapeutics. Peptide and Peptidomimetic Therapeutics
521
550
.
Ilka Günther, Gerald Rimbach, Sandra Nevermann, Cathrina Neuhauser, Verena Stadlbauer, Bettina Schwarzinger, Clemens Schwarzinger, Ignacio R. Ipharraguerre, Julian Weghuber & Kai Lüersen. (2021) Avens Root (Geum Urbanum L.) Extract Discovered by Target-Based Screening Exhibits Antidiabetic Activity in the Hen’s Egg Test Model and Drosophila melanogaster. Frontiers in Pharmacology 12.
Crossref
Crossref
Shivangi Agarwal, Yashwanth R. Sudhini, Onur K. Polat, Jochen Reiser & Mehmet M. Altintas. (2021) Renal cell markers: lighthouses for managing renal diseases. American Journal of Physiology-Renal Physiology 321:6, pages F715-F739.
Crossref
Crossref
John Wong, Kwan Yi Chan & Kenneth Lo. (2021) Sodium‐glucose co‐transporter 2 inhibitors on weight change and cardiometabolic profiles in individuals with overweight or obesity and without diabetes: A meta‐analysis. Obesity Reviews 22:12.
Crossref
Crossref
Ziqi Hu, Yanjun Liao, Jing Wang, Xiaohua Wen & Luan Shu. (2021) Potential impacts of diabetes mellitus and anti-diabetes agents on expressions of sodium-glucose transporters (SGLTs) in mice. Endocrine 74:3, pages 571-581.
Crossref
Crossref
Karan Matharu, Kiran Chana, Charles J. Ferro & Alan M. Jones. (2021) Polypharmacology of clinical sodium glucose co‐transport protein 2 inhibitors and relationship to suspected adverse drug reactions. Pharmacology Research & Perspectives 9:5.
Crossref
Crossref
Xiaoya Zhao, Bingqi Dong, Marissa Friesen, Shangxi Liu, Changqing Zhu & Chengbo Yang. (2021) Capsaicin Attenuates Lipopolysaccharide-Induced Inflammation and Barrier Dysfunction in Intestinal Porcine Epithelial Cell Line-J2. Frontiers in Physiology 12.
Crossref
Crossref
Ivana Vrhovac Madunić, Valentina Karin-Kujundžić, Josip Madunić, Ida Marija Šola & Ljiljana Šerman. (2021) Endometrial Glucose Transporters in Health and Disease. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Scott W. Murray, Sean McKelvey, Thomas D. Heseltine, George Henderson, Jagdeep Singh, David Unwin & Adrian J. B. Brady. (2021) The “discordant doppelganger dilemma”: SGLT2i mimics therapeutic carbohydrate restriction - food choice first over pharma?. Journal of Human Hypertension 35:8, pages 649-656.
Crossref
Crossref
Vincenzo Maria Monda, Francesca Porcellati, Felice Strollo, Alessandro Fucili, Marcello Monesi, Ersilia Satta & Sandro Gentile. (2021) Possible Preventative/Rehabilitative Role of Gliflozins in OSA and T2DM. A Systematic Literature Review-Based Hypothesis. Advances in Therapy 38:8, pages 4195-4214.
Crossref
Crossref
Tapan Behl, Aayush Sehgal, Madhuri Grover, Sukhbir Singh, Neelam Sharma, Saurabh Bhatia, Ahmed Al-Harrasi, Lotfi Aleya & Simona Bungau. (2021) Uncurtaining the pivotal role of ABC transporters in diabetes mellitus. Environmental Science and Pollution Research 28:31, pages 41533-41551.
Crossref
Crossref
William G. Herrington, Gianluigi Savarese, Richard Haynes, Nikolaus Marx, Linda Mellbin, Lars H. Lund, Paul Dendale, Petar Seferovic, Giuseppe Rosano, Natalie Staplin, Colin Baigent & Francesco Cosentino. (2021) Cardiac, renal, and metabolic effects of sodium–glucose co‐transporter 2 inhibitors: a position paper from the European Society of Cardiology ad‐hoc task force on sodium–glucose co‐transporter 2 inhibitors. European Journal of Heart Failure 23:8, pages 1260-1275.
Crossref
Crossref
Anu Grover, Komal Sharma, Suresh Gautam, Srishti Gautam, Monica Gulati & Sachin Kumar Singh. (2021) Diabetes and Its Complications: Therapies Available, Anticipated and Aspired. Current Diabetes Reviews 17:4, pages 397-420.
Crossref
Crossref
Zhenjie Sun, Qian Chai, Ziying Zhang, Dexue Lu, Ziang Meng & Weihua Wu. (2021) Inhibition of SGLT1 protects against glycemic variability-induced cardiac damage and pyroptosis of cardiomyocytes in diabetic mice. Life Sciences 271, pages 119116.
Crossref
Crossref
Jacob E. Pruett, Edgar D. Torres Fernandez, Steven J. Everman, Ruth M. Vinson, Kacey Davenport, Madelyn K. Logan, Stephanie A. Ye, Damian G. Romero & Licy L. Yanes Cardozo. (2021) Impact of SGLT-2 Inhibition on Cardiometabolic Abnormalities in a Rat Model of Polycystic Ovary Syndrome. International Journal of Molecular Sciences 22:5, pages 2576.
Crossref
Crossref
Laura Ferté, Alice Marino, Sylvain Battault, Laurent Bultot, Anne Van Steenbergen, Anne Bol, Julien Cumps, Audrey Ginion, Hermann Koepsell, Laure Dumoutier, Louis Hue, Sandrine Horman, Luc Bertrand & Christophe Beauloye. (2021) New insight in understanding the contribution of SGLT1 in cardiac glucose uptake: evidence for a truncated form in mice and humans. American Journal of Physiology-Heart and Circulatory Physiology 320:2, pages H838-H853.
Crossref
Crossref
Na Lin, Hui Lin, Qi Yang, Wenqiang Lu, Zhenzhu Sun, Shimin Sun, Liping Meng, Jufang Chi & Hangyuan Guo. (2021) SGLT1 Inhibition Attenuates Apoptosis in Diabetic Cardiomyopathy via the JNK and p38 Pathway. Frontiers in Pharmacology 11.
Crossref
Crossref
Johan H Jendle, Francisco J Ampudia-Blasco, Martin Füchtenbusch & Paolo Pozzilli. (2021) Dapagliflozin as an Adjunct Therapy to Insulin in Patients with Type 1 Diabetes Mellitus: Efficacy and Safety of this Combination. touchREVIEWS in Endocrinology 17:1, pages 12.
Crossref
Crossref
Worood Sirhan & Ron Piran. (2020) Current Approaches in Diabetes Treatment and Other Strategies to Reach Normoglycemia. Current Topics in Medicinal Chemistry 20:32, pages 2922-2944.
Crossref
Crossref
Ken Ohara, Takahiro Masuda, Masato Morinari, Mari Okada, Atsushi Miki, Saki Nakagawa, Takuya Murakami, Kentaro Oka, Maki Asakura, Yasuharu Miyazawa, Akito Maeshima, Tetsu Akimoto, Osamu Saito & Daisuke Nagata. (2020) The extracellular volume status predicts body fluid response to SGLT2 inhibitor dapagliflozin in diabetic kidney disease. Diabetology & Metabolic Syndrome 12:1.
Crossref
Crossref
David J. Mela, Xiu-Zhen Cao, Rajendra Dobriyal, Mark I. Fowler, Li Lin, Manoj Joshi, Theo J. P. Mulder, Peter G. Murray, Harry P. F. Peters, Mario A. Vermeer & Zhang Zhang. (2020) The effect of 8 plant extracts and combinations on post-prandial blood glucose and insulin responses in healthy adults: a randomized controlled trial. Nutrition & Metabolism 17:1.
Crossref
Crossref
Christoph Otto, Alexandra Friedrich, Ivana Vrhovac Madunić, Christian Baumeier, Robert W. Schwenk, Dean Karaica, Christoph-Thomas Germer, Annette Schürmann, Ivan Sabolić & Hermann Koepsell. (2020)
Antidiabetic Effects of a Tripeptide That Decreases Abundance of Na
+
-
d
-glucose Cotransporter SGLT1 in the Brush-Border Membrane of the Small Intestine
. ACS Omega 5:45, pages 29127-29139.
Crossref
Crossref
Helena W. Rodbard, Andrea Giaccari, Rosemarie Lajara, John Stewart, Paul S. Strumph, Juliana Oliveira, Pablo Lapuerta & Rita Castro. (2020)
Sotagliflozin added to optimized insulin therapy leads to
HbA1c
reduction without weight gain in adults with type 1 diabetes: A pooled analysis of
inTandem1
and
inTandem2
. Diabetes, Obesity and Metabolism 22:11, pages 2089-2096.
Crossref
Crossref
Theresa F. Rambaran, Nyron Nembhard, Camille S. Bowen‐Forbes & Ruby L. Alexander‐Lindo. (2020)
Hypoglycemic effect of the fruit extracts of two varieties of
Rubus rosifolius
. Journal of Food Biochemistry 44:9.
Crossref
Crossref
Volker Vallon. (2020) Glucose transporters in the kidney in health and disease. Pflügers Archiv - European Journal of Physiology 472:9, pages 1345-1370.
Crossref
Crossref
Cong Xie, Karen L. Jones, Christopher K. Rayner & Tongzhi Wu. (2020) Enteroendocrine Hormone Secretion and Metabolic Control: Importance of the Region of the Gut Stimulation. Pharmaceutics 12:9, pages 790.
Crossref
Crossref
Miguel Valdés, Fernando Calzada, Jessica Elena Mendieta-Wejebe, Verenice Merlín-Lucas, Claudia Velázquez & Elizabeth Barbosa. (2020) Antihyperglycemic Effects of Annona diversifolia Safford and Its Acyclic Terpenoids: α-Glucosidase and Selective SGLT1 Inhibitiors. Molecules 25:15, pages 3361.
Crossref
Crossref
Ryuhei Sano, Yuichi Shinozaki & Takeshi Ohta. (2020) Sodium–glucose cotransporters: Functional properties and pharmaceutical potential. Journal of Diabetes Investigation 11:4, pages 770-782.
Crossref
Crossref
Theresa F Rambaran, Jonathan Bergman, Peter Nordström & Anna Nordström. (2020) Effect of Berry Polyphenols on Glucose Metabolism: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Current Developments in Nutrition 4:7, pages nzaa100.
Crossref
Crossref
Suyun Li, Jin Liu, Zheng Li, Liqin Wang, Weina Gao, Zhenqing Zhang & Changjiang Guo. (2020) Sodium-dependent glucose transporter 1 and glucose transporter 2 mediate intestinal transport of quercetrin in Caco-2 cells. Food & Nutrition Research 64:0.
Crossref
Crossref
Volker Vallon & Scott C. Thomson. (2020) The tubular hypothesis of nephron filtration and diabetic kidney disease. Nature Reviews Nephrology 16:6, pages 317-336.
Crossref
Crossref
Victor Sokolov, Tatiana Yakovleva, Lulu Chu, Weifeng Tang, Peter J. Greasley, Susanne Johansson, Kirill Peskov, Gabriel Helmlinger, David W. Boulton & Robert C. Penland. (2020) Differentiating the Sodium‐Glucose Cotransporter 1 Inhibition Capacity of Canagliflozin vs. Dapagliflozin and Empagliflozin Using Quantitative Systems Pharmacology Modeling. CPT: Pharmacometrics & Systems Pharmacology 9:4, pages 222-229.
Crossref
Crossref
Brent A. Neuschwander-Tetri. (2020) Therapeutic Landscape for NAFLD in 2020. Gastroenterology.
Crossref
Crossref
Bryony E. Langford, Marc Evans, Tao Haskins‐Coulter, Molly O'Connor, Harriet E. O. Cant, Lucy A. Eddowes, Christopher Edmonds & Amarjeet Tank. (2019) Systematic literature review and network meta‐analysis of sodium‐glucose co‐transporter inhibitors vs metformin as add‐on to insulin in type 1 diabetes. Diabetes, Obesity and Metabolism 22:1, pages 39-50.
Crossref
Crossref
Beatriz Merino, Cristina M. Fernández-Díaz, Irene Cózar-Castellano & German Perdomo. (2019) Intestinal Fructose and Glucose Metabolism in Health and Disease. Nutrients 12:1, pages 94.
Crossref
Crossref
Lihua Ye, Olaf Mueller, Jennifer Bagwell, Michel Bagnat, Rodger A Liddle & John F Rawls. (2019) High fat diet induces microbiota-dependent silencing of enteroendocrine cells. eLife 8.
Crossref
Crossref
Alana Aragón-Herrera, Sandra Feijóo-Bandín, Manuel Otero Santiago, Luis Barral, Manuel Campos-Toimil, José Gil-Longo, Thiago M. Costa Pereira, Tomás García-Caballero, Santiago Rodríguez-Segade, Javier Rodríguez, Estefanía Tarazón, Esther Roselló-Lletí, Manuel Portolés, Oreste Gualillo, José Ramón González-Juanatey & Francisca Lago. (2019) Empagliflozin reduces the levels of CD36 and cardiotoxic lipids while improving autophagy in the hearts of Zucker diabetic fatty rats. Biochemical Pharmacology 170, pages 113677.
Crossref
Crossref
Reyhaneh Moradi‐Marjaneh, Maryam Paseban & Amirhossein Sahebkar. (2019) Natural products with SGLT2 inhibitory activity: Possibilities of application for the treatment of diabetes. Phytotherapy Research 33:10, pages 2518-2530.
Crossref
Crossref
Paul Oranje, Robin Gouka, Lindsey Burggraaff, Mario Vermeer, Clément Chalet, Guus Duchateau, Pieter van der Pijl, Marian Geldof, Niels de Roo, Fenja Clauwaert, Toon Vanpaeschen, Johan Nicolaï, Tom de Bruyn, Pieter Annaert, Adriaan P. IJzerman & Gerard J. P. van Westen. (2019) Novel natural and synthetic inhibitors of solute carriers SGLT1 and SGLT2. Pharmacology Research & Perspectives 7:4.
Crossref
Crossref
Álvaro García-Ropero, Ariana P. Vargas-Delgado, Carlos G. Santos-Gallego & Juan J. Badimon. (2019) Inhibition of Sodium Glucose Cotransporters Improves Cardiac Performance. International Journal of Molecular Sciences 20:13, pages 3289.
Crossref
Crossref
Panai Song, Winnie Huang, Akira Onishi, Rohit Patel, Young Chul Kim, Charlotte van Ginkel, Yiling Fu, Brent Freeman, Hermann Koepsell, Scott Thomson, Ruisheng Liu & Volker Vallon. (2019)
Knockout of Na
+
-glucose cotransporter SGLT1 mitigates diabetes-induced upregulation of nitric oxide synthase NOS1 in the macula densa and glomerular hyperfiltration
. American Journal of Physiology-Renal Physiology 317:1, pages F207-F217.
Crossref
Crossref
Michael Morkos, Nasha K Nensey & Anila Bindal. (2019) Micafungin-Induced Hypoglycemia in a Patient With Type 1 Diabetes: A Case Report and Review of Literature. The Journal of Clinical Endocrinology & Metabolism 104:4, pages 981-984.
Crossref
Crossref
Jessica A. Dominguez Rieg & Timo Rieg. (2019) What does sodium‐glucose co‐transporter 1 inhibition add: Prospects for dual inhibition. Diabetes, Obesity and Metabolism 21:S2, pages 43-52.
Crossref
Crossref
L. V. Gromova, A. S. Polozov, O. V. Kornyushin, N. M. Grefner, Yu. V. Dmitrieva, A. S. Alekseeva & A. A. Gruzdkov. (2019) Glucose Absorption in the Rat Small Intestine under Experimental Type 2 Diabetes Mellitus. Journal of Evolutionary Biochemistry and Physiology 55:2, pages 155-157.
Crossref
Crossref
Fabiola Moreno-Olivas, Elad Tako & Gretchen J. Mahler. (2019) ZnO nanoparticles affect nutrient transport in an in vitro model of the small intestine. Food and Chemical Toxicology 124, pages 112-127.
Crossref
Crossref
Shoichi Kuroda, Yohei Kobashi, Takahiro Oi, Kenichi Kawabe, Fumiyasu Shiozawa, Lisa Okumura-Kitajima, Mami Sugisaki-Kitano, Fusayo Io, Koji Yamamoto & Hiroyuki Kakinuma. (2019) Discovery of potent, low-absorbable sodium-dependent glucose cotransporter 1 (SGLT1) inhibitor SGL5213 for type 2 diabetes treatment. Bioorganic & Medicinal Chemistry 27:2, pages 394-409.
Crossref
Crossref
Nan Wang, Shuai Li, Xiao-chen Guo, Jun-yan Li, Gui-ping Ren & De-shan Li. (2019) Fibroblast growth factor 21 improves glucose homeostasis partially via down-regulation of Na+-d-glucose cotransporter SGLT1 in the small intestine. Biomedicine & Pharmacotherapy 109, pages 1070-1077.
Crossref
Crossref
Denisha Spires, Anna D. Manis & Alexander Staruschenko. 2019. Membrane Transporters in the Pathogenesis of Cardiovascular and Lung Disorders. Membrane Transporters in the Pathogenesis of Cardiovascular and Lung Disorders
353
396
.
Jothydev Kesavadev, Fatema Jawad, Asma Deeb, Ankia Coetzee, M. A. Jalil Ansari, Dina Shrestha, Noel Somasundaram & Sanjay Kalra. 2019. The Diabetes Textbook. The Diabetes Textbook
101
116
.
Kim A. Connelly, Yanling Zhang, Jean-François Desjardins, Kerri Thai & Richard E. Gilbert. (2018) Dual inhibition of sodium–glucose linked cotransporters 1 and 2 exacerbates cardiac dysfunction following experimental myocardial infarction. Cardiovascular Diabetology 17:1.
Crossref
Crossref
Shoichi Kuroda, Yohei Kobashi, Takahiro Oi, Hideaki Amada, Lisa Okumura-Kitajima, Fusayo Io, Koji Yamamto & Hiroyuki Kakinuma. (2018) Discovery of a potent, low-absorbable sodium-dependent glucose cotransporter 1 (SGLT1) inhibitor (TP0438836) for the treatment of type 2 diabetes. Bioorganic & Medicinal Chemistry Letters 28:22, pages 3534-3539.
Crossref
Crossref
Pavel Balazki, Stephan Schaller, Thomas Eissing & Thorsten Lehr. (2018)
A Quantitative Systems Pharmacology Kidney Model of Diabetes Associated Renal Hyperfiltration and the Effects of
SGLT
Inhibitors
. CPT: Pharmacometrics & Systems Pharmacology 7:12, pages 788-797.
Crossref
Crossref
Blythe D Shepard, Hermann Koepsell & Jennifer L. Pluznick. (2018) Renal Olfactory Receptor 1393 Contributes to the Progression of Type II Diabetes in a Diet-Induced Obesity Model. American Journal of Physiology-Renal Physiology.
Crossref
Crossref
Nicholas M. Dalesio, Sebastian F. Barreto Ortiz, Jennifer L. Pluznick & Dan E. Berkowitz. (2018) Olfactory, Taste, and Photo Sensory Receptors in Non-sensory Organs: It Just Makes Sense. Frontiers in Physiology 9.
Crossref
Crossref
Vasilis Tsimihodimos, Sebastien Filippas-Ntekouan & Moses Elisaf. (2018) SGLT1 inhibition: Pros and cons. European Journal of Pharmacology 838, pages 153-156.
Crossref
Crossref
Lorea Zubiaga, Ramón Vilallonga, Jaime Ruiz-Tovar, Antonio Torres & François Pattou. (2018) Importancia del tracto gastrointestinal en la diabetes de tipo 2. La cirugía metabólica es más que incretinas. Cirugía Española 96:9, pages 537-545.
Crossref
Crossref
Lorea Zubiaga, Ramón Vilallonga, Jaime Ruiz-Tovar, Antonio Torres & François Pattou. (2018) Importance of the Gastrointestinal Tract in Type 2 Diabetes. Metabolic Surgery Is More Than Just Incretin Effect. Cirugía Española (English Edition) 96:9, pages 537-545.
Crossref
Crossref
Nelson Andrade, Cláudia Silva & Fátima Martel. (2018)
The effect of oxidative stress upon intestinal sugar transport: an
in vitro
study using human intestinal epithelial (Caco-2) cells
. Toxicology Research 7:6, pages 1236-1246.
Crossref
Crossref
Katharina Schreck & Matthias F. Melzig. (2018) Intestinal Saturated Long-Chain Fatty Acid, Glucose and Fructose Transporters and Their Inhibition by Natural Plant Extracts in Caco-2 Cells. Molecules 23:10, pages 2544.
Crossref
Crossref
Timo Rieg & Volker Vallon. (2018) Development of SGLT1 and SGLT2 inhibitors. Diabetologia 61:10, pages 2079-2086.
Crossref
Crossref
Markus Mühlemann, Daniela Zdzieblo, Alexandra Friedrich, Constantin Berger, Christoph Otto, Heike Walles, Hermann Koepsell & Marco Metzger. (2018) Altered pancreatic islet morphology and function in SGLT1 knockout mice on a glucose-deficient, fat-enriched diet. Molecular Metabolism 13, pages 67-76.
Crossref
Crossref
Dorrin Zarrin Khat & Mansoor Husain. (2018) Molecular Mechanisms Underlying the Cardiovascular Benefits of SGLT2i and GLP-1RA. Current Diabetes Reports 18:7.
Crossref
Crossref
Fuyong Du, Simon A. Hinke, Cassandre Cavanaugh, David Polidori, Nathanial Wallace, Thomas Kirchner, Matthew Jennis, Wensheng Lang, Gee-Hong Kuo, Micheal D. Gaul, James Lenhard, Keith Demarest, Nadim J. Ajami, Yin Liang & Pamela J. Hornby. (2018) Potent Sodium/Glucose Cotransporter SGLT1/2 Dual Inhibition Improves Glycemic Control Without Marked Gastrointestinal Adaptation or Colonic Microbiota Changes in Rodents. Journal of Pharmacology and Experimental Therapeutics 365:3, pages 676-687.
Crossref
Crossref
U. Varma, P. Koutsifeli, V.L. Benson, K.M. Mellor & L.M.D. Delbridge. (2018) Molecular mechanisms of cardiac pathology in diabetes – Experimental insights. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1864:5, pages 1949-1959.
Crossref
Crossref
Hadi Fattah & Volker Vallon. (2018) The Potential Role of SGLT2 Inhibitors in the Treatment of Type 1 Diabetes Mellitus. Drugs 78:7, pages 717-726.
Crossref
Crossref
Liping Meng, Hiroyasu Uzui, Hangyuan Guo & Hiroshi Tada. (2018) Role of SGLT1 in high glucose level-induced MMP-2 expression in human cardiac fibroblasts. Molecular Medicine Reports.
Crossref
Crossref
Lin Han, Lingling Zhang, Wenfang Ma, Ding Li, Rujie Shi & Min Wang. (2018)
Proanthocyanidin B
2
attenuates postprandial blood glucose and its inhibitory effect on alpha-glucosidase: analysis by kinetics, fluorescence spectroscopy, atomic force microscopy and molecular docking
. Food & Function 9:9, pages 4673-4682.
Crossref
Crossref
Fabiola Moreno-Olivas, Elad Tako & Gretchen J. Mahler. (2018)
Retracted Article: ZnO nanoparticles affect intestinal function in an
in vitro
model
. Food & Function 9:3, pages 1475-1491.
Crossref
Crossref
Letizia Zeni, Anthony G. W. Norden, Giovanni Cancarini & Robert J. Unwin. (2017) A more tubulocentric view of diabetic kidney disease. Journal of Nephrology 30:6, pages 701-717.
Crossref
Crossref
Ernest M. Wright, Chiara Ghezzi & Donald D. F. Loo. (2017) Novel and Unexpected Functions of SGLTs. Physiology 32:6, pages 435-443.
Crossref
Crossref
Madhuri S. Salker, Yogesh Singh, Ni Zeng, Hong Chen, Shaqiu Zhang, Anja T Umbach, Hajar Fakhri, Ursula Kohlhofer, Leticia Quintanilla-Martinez, Ruban R. Peter Durairaj, Flavio S. V. Barros, Pavle Vrljicak, Sascha Ott, Sara Y Brucker, Diethelm Wallwiener, Ivana Vrhovac Madunić, Davorka Breljak, Ivan Sabolić, Hermann Koepsell, Jan J. Brosens & Florian Lang. (2017) Loss of Endometrial Sodium Glucose Cotransporter SGLT1 is Detrimental to Embryo Survival and Fetal Growth in Pregnancy. Scientific Reports 7:1.
Crossref
Crossref
Hermann Koepsell. (2017) The Na+-D-glucose cotransporters SGLT1 and SGLT2 are targets for the treatment of diabetes and cancer. Pharmacology & Therapeutics 170, pages 148-165.
Crossref
Crossref
Volker Vallon & Scott C. Thomson. (2016) Targeting renal glucose reabsorption to treat hyperglycaemia: the pleiotropic effects of SGLT2 inhibition. Diabetologia 60:2, pages 215-225.
Crossref
Crossref
Anne Van Steenbergen, Magali Balteau, Audrey Ginion, Laura Ferté, Sylvain Battault, Christophe de Meester de Ravenstein, Jean-Luc Balligand, Evangelos-Panagiotis Daskalopoulos, Patrick Gilon, Florin Despa, Sanda Despa, Jean-Louis Vanoverschelde, Sandrine Horman, Hermann Koepsell, Gerard Berry, Louis Hue, Luc Bertrand & Christophe Beauloye. (2017) Sodium-myoinositol cotransporter-1, SMIT1, mediates the production of reactive oxygen species induced by hyperglycemia in the heart. Scientific Reports 7:1.
Crossref
Crossref
Wen-Ling Zheng, Chao Chu, Yong-Bo Lv, Yang Wang, Jia-Wen Hu, Qiong Ma, Yu Yan, Yu-Meng Cao, Xi-Long Dang, Ke-Ke Wang & Jian-Jun Mu. (2017) Effect of Salt Intake on Serum Glucagon-Like Peptide-1 Levels in Normotensive Salt-Sensitive Subjects. Kidney and Blood Pressure Research 42:4, pages 728-737.
Crossref
Crossref
Mat?? Sot?k, Joanne Marks & Robert J. Unwin. (2017) Putative tissue location and function of the SLC5 family member SGLT3. Experimental Physiology 102:1, pages 5-13.
Crossref
Crossref
Ralph A. DeFronzo, Luke Norton & Muhammad Abdul-Ghani. (2016) Renal, metabolic and cardiovascular considerations of SGLT2 inhibition. Nature Reviews Nephrology 13:1, pages 11-26.
Crossref
Crossref